1. Home
  2. GSUN vs GNPX Comparison

GSUN vs GNPX Comparison

Compare GSUN & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

N/A

Current Price

$0.23

Market Cap

2.7M

Sector

Real Estate

ML Signal

N/A

Logo Genprex Inc.

GNPX

Genprex Inc.

N/A

Current Price

$3.35

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSUN
GNPX
Founded
1997
2009
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.9M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
GSUN
GNPX
Price
$0.23
$3.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.2M
82.1K
Earning Date
02-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.16
52 Week High
$3.31
$12.97

Technical Indicators

Market Signals
Indicator
GSUN
GNPX
Relative Strength Index (RSI) 41.29 38.51
Support Level $0.17 $1.88
Resistance Level $0.55 $3.62
Average True Range (ATR) 0.07 0.19
MACD -0.00 -0.03
Stochastic Oscillator 9.78 1.30

Price Performance

Historical Comparison
GSUN
GNPX

About GSUN Golden Sun Education Group Limited

Golden Sun Technology Group Ltd operates two principal lines of business: tutorial services and e-commerce services. The company's e-commerce operations currently consist of data analytics-driven marketing and social media promotional services for small and medium-sized businesses on short video platforms based in China. The company's education centers offer two main programs, comprising of foreign language tutorial programs in less commonly taught languages, including, among other things, Spanish and Japanese, provided to individual students as well as to companies and other organizations; and Gaokao repeater tutorial programs, provided to individual students.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Share on Social Networks: